Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management
Authors:
- Chengjun YaoCYChengjun Yao
- Haiying ZhouHZHaiying Zhou
- Yanzhao DongYDYanzhao Dong
- Ahmad AlhaskawiAAAhmad Alhaskawi
- Sohaib Hasan Abdullah EzziSESohaib Hasan Abdullah Ezzi
- Zewei WangZWZewei Wang
- Jingtian LaiJLJingtian Lai
- Vishnu Goutham KotaVKVishnu Goutham Kota
- Mohamed Hasan Abdulla Hasan AbdullaMAMohamed Hasan Abdulla Hasan Abdulla
- Hui LuHui Lu
Top Cited Papers
Open Access
Abstract
Malignant peripheral nerve sheath tumor (MPNST) is an aggressive soft tissue sarcoma with limited therapeutic options and a poor prognosis. Although neurofibromatosis type 1 (NF1) and radiation exposure have been identified as risk factors for MPNST, the genetic and molecular mechanisms underlying MPNST pathogenesis have only lately been roughly elucidated. Plexiform neurofibroma (PN) and atypical neurofibromatous neoplasm of unknown biological potential (ANNUBP) are novel concepts of MPNST precancerous lesions, which revealed sequential mutations in MPNST development. This review summarized the current understanding of MPNST and the latest consensus from its diagnosis to treatment, with highlights on molecular biomarkers and targeted therapies. Additionally, we discussed the current challenges and prospects for MPNST management.Keywords
Funding Information
- Zhejiang Provincial Natural Science Foundation Academic Exchange Program (LY20H060007)
This publication has 125 references indexed in Scilit:
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Neuro-Oncology, 2012
- Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous systemBrain Research Bulletin, 2012
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven TumorsCancer Cell, 2011
- Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989European Journal of Human Genetics, 2011
- The Polycomb complex PRC2 and its mark in lifeNature, 2011
- First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group studyAnnals of Oncology, 2010
- Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benignCancer, 2009
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone MarrowCell, 2008
- Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing CellsCancer Cell, 2008
- Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplificationJournal of Medical Genetics, 2007